Tandem Diabetes上调私募配售规模,定价2.65亿美元2032年到期可转换优先票据

美股速递
Feb 25

Tandem Diabetes Care近日完成规模扩大的私募配售,成功定价2.65亿美元于2032年到期的可转换优先票据。此次发行规模较原计划有所提升,反映出市场对该公司金融工具的强劲需求。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10